Boost for global access to diabetes treatments
Two established diabetes medicines have been given the green light for use outside the EU – even when stored at higher temperatures – under the EU Medicines for… read more.
Two established diabetes medicines have been given the green light for use outside the EU – even when stored at higher temperatures – under the EU Medicines for… read more.
Children with autism spectrum disorder tend to experience gastrointestinal issues, such as constipation and stomach pain, at a higher rate than their neurotypical peers. Some also experience other… read more.
Cognitive development in children could be affected regardless of which biological parent has type 1 diabetes, according to research publishing April 19 in the open access journal PLOS Medicine. The… read more.
Adjunctive dapagliflozin therapy appears to improve outcomes in heart failure patients without regard to frailty status at initiation of treatment. These findings appeared on April 26, 2022 in… read more.
People could benefit from fully automated personal nutritional advice, as a new research paper shows that an app improved healthy diet in clinical trials. A paper published in… read more.
A third of healthcare workers took sick leave after being vaccinated against COVID-19, a German study presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases… read more.
Kläre Bryant is an experienced clinical pharmacist who has specialised in dermatology. For the past nine years she run outpatient clinics at Liverpool University Hospitals for dermatology patients… read more.
A recent study by the Faculty of Sport and Health Sciences at the University of Jyväskylä and the Gerontology Research Center (Finland) investigated the paths from childhood socioemotional… read more.
There is now an interest group for specialist dermatology pharmacists and work is in progress with British Association of Dermatologists to develop suitable training. As Kläre Bryant, advanced… read more.
Amgen announced results from a pooled post-hoc analysis of the pivotal NAVIGATOR Phase III and PATHWAY Phase IIb trials showed Tezspire (tezepelumab-ekko) demonstrated reductions in the annualized asthma… read more.
Kläre Bryant, advanced clinical pharmacist in dermatology at Liverpool University Hospitals, was a recently-qualified independent prescriber when she managed the switch to biosimilar infliximab for the cohort of… read more.
Almost three-quarters of antibiotics prescriptions to patients aged 65 years or older, and two thirds to Black patients, are inappropriate, according to a study analysing over 7 billion… read more.